← FDA DRUG APPROVALS

FDA ANDA · ANDA078442

ALPRAZOLAM

Sponsor: PH HEALTH

APPLICATION
ANDA078442
TYPE
ANDA
ORIGINAL APPROVAL
2007-10-15
LATEST ACTION
2011-11-29
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ALPRAZOLAMDiscontinued
ALPRAZOLAM 3MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 1MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 2MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.5MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2011-11-29Labeling · Supplement 2AP
2007-10-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →